Links to all GeneRIF Items | 10568 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 24194864 (Slc34a2) | Knockdown of the sodium-dependent phosphate co-transporter 2b (NPT2b) suppresses lung tumorigenesis. |
| 21956469 (SLC34A2) | study provides the data on the pattern of NaPi2b expression and cellular localization in breast, lung and ovarian cancers |
| 25017204 (SLC34A2) | SLC34A2 might be associated with the initiation and progression of lung adenocarcinoma |
| 26156586 (SLC34A2) | our data indicated that SLC34A2 could exert significantly suppressive effects on tumorigenesis and progression of NSCLC. SLC34A2 might provide new insights for further understanding the early pathogenesis of human non-small cell lung cancer |
| 26846105 (SLC34A2) | Our work sheds new light on the nature of the state of lung cancer stem cell-like cells and the role of SLC34A2 in the tumorigenicity of these cells |
| 26910912 (SLC34A2) | Low SLC34A2 expression is associated with non-small cell lung cancer. |
| 30262706 (SLC34A2) | The upstream breakpoint lies in the same region as the breakpoint of a fused gene SLC34A2-ROS1, which encodes a constitutive kinase in the lung cancer cell line HCC78 and nonsmall-cell lung cancer (NSCLC), suggesting that the deletion in this family is a hot spot for recombination, not only in cancer samples with somatic mutation, but also in PAM patients with germline genetic defects of SLC34A2. |
| 31540980 (SLC34A2) | Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell lung cancer and Platinum-Resistant Ovarian cancer. |